Pancreatic Cancer Research

ResearcherShanghai East HospitalNo recent work listed

Jin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-3094-4777; OpenAlex author ID A5086267115. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 1, last author 0)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2019: 1 trial · 2020: 1 trial · 2021: none · 2022: 1 trial · 2023: 1 paper

Papers 1

  1. Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. First author DOI 10.1200/jco.22.02630↗

Trials 3

  1. A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors Principal investigator NCT05621486↗
  2. Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors Principal investigator NCT04400383↗
  3. A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors Principal investigator NCT06239155↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shukui Qin · 1 shared trial, 2019 · strength 0.30
  2. Chunyi Hao · 1 shared paper, 2023 · strength 0.13
  3. Ying Yuan · 1 shared paper, 2023 · strength 0.13
  4. Hongmei Zhang · 1 shared paper, 2023 · strength 0.13
  5. Lin Yang · 1 shared paper, 2023 · strength 0.13
  6. Lin Shen · 1 shared paper, 2023 · strength 0.13
  7. Jianming Xu · 1 shared paper, 2023 · strength 0.13
  8. Rui‐Hua Xu · 1 shared paper, 2023 · strength 0.13
  9. Qingshan Zheng · 1 shared paper, 2023 · strength 0.13
  10. Jun Zhang · 1 shared paper, 2023 · strength 0.13
  11. Shukui Qin · 1 shared paper, 2023 · strength 0.13
  12. Deliang Fu · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.